# Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Study · id `cardio:ct-nct07025980` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07025980](<https://clinicaltrials.gov/study/NCT07025980>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07025980

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; High blood pressure; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 114 participants.

## Technical summary

Registry record NCT07025980. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-01 (anticipated); primary completion 2028-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 114 participants (planned count; ClinicalTrials.gov record NCT07025980, source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)
- Planned start: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT07025980, source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)
- Primary completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT07025980, source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)
- Completion: 2029-07-31 (anticipated) (ClinicalTrials.gov record NCT07025980, source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)
- Countries: Croatia (ClinicalTrials.gov record NCT07025980, source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07025980-2025-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.
- Condition: MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
- Condition: Diabetes Mellitus
- Condition: Hypertension
- Condition: Hyperlipidaemia
- Intervention (Dietary supplement): The test product is a ready-to-use sinbiotic preparation of multispecies probiotics, ca-butyrate and FOS
- Intervention (Dietary supplement): Placebo Drug
- Lead sponsor: Eva Cubric
- Lead sponsor class: OTHER
- Collaborator: General Hospital Šibenik, Croatia
- Collaborator class: OTHER
- Collaborator: General Hospital Zadar
- Collaborator class: OTHER
- Collaborator: University Hospital Dubrava
- Collaborator class: OTHER
- Collaborator: University Hospital Rijeka
- Collaborator class: OTHER
- Collaborator: Clinical Hospital Merkur
- Collaborator class: OTHER
- Collaborator: University Hospital Sestre Milosrdnice
- Collaborator class: OTHER
- Collaborator: University Hospital of Split
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: a559db214e054bef732f163899fb4c47db82ec73a67741f2128d6d1b408432c2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
